comparemela.com

Latest Breaking News On - San raffaele scientific institute - Page 3 : comparemela.com

How Accurately Can ChatGPT Answer Cardiac Arrest Queries?

Zanubrutinib Improves PFS in Treatment-Naive CLL/SLL, Regardless of Complex Karyotypes

Paolo Ghia, MD, PhD, describes the various cohorts of the SEQUOIA study, expands on outcomes from a biomarker subgroup analysis with zanubrutinib vs bendamustine plus rituximab, and more.

Atezolizumab regimen confers boost in response rates in certain women with breast cancer

Atezolizumab regimen confers boost in response rates in certain women with breast cancer
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Dr Ghia on a Biomarker Analysis of the SEQUOIA Trial in CLL/SLL

Paolo Ghia, MD, PhD, full professor, discusses a biomarker subgroup analysis of the phase 3 SEQUOIA trial investigating zanubrutinib vs bendamustine plus rituximab in patients with treatment-naive chronic lymphocytic leukemia or small lymphocytic lymphoma without 17p deletions.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.